Investors & Media Press Releases Investor Relations Overview Corporate Governance Press Releases Events & Presentations SEC Filings Annuals and Proxies Investor FAQs Financials & Filings Stock Information Analyst Coverage Email Alerts Subscription Notice of Pendency of Settlement of Action Press Releases Year: - Any -20232022202120202019201820172016201520142013 Items per page 102550 Date Title View Toggle SummaryDec 19, 2013 SAGE Therapeutics Announces Collaboration with Washington University to Develop Novel GABA Receptor Small Molecules SAGE Therapeutics Announces Collaboration with Washington University to Develop Novel GABA Receptor Small Molecules View HTML PDF Version Toggle SummaryDec 9, 2013 SAGE Therapeutics Presents New Data Identifying Highly Selective, Oral Compounds and Novel Approach for the Treatment of Chronic Epilepsies SAGE Therapeutics Presents New Data Identifying Highly Selective, Oral Compounds and Novel Approach for the Treatment of Chronic Epilepsies View HTML PDF Version Toggle SummaryNov 18, 2013 SAGE's Novel Approach to Treatment of CNS Disorders to be Highlighted at Leading Industry and Scientific Conferences SAGE's Novel Approach to Treatment of CNS Disorders to be Highlighted at Leading Industry and Scientific Conferences View HTML PDF Version Toggle SummaryNov 12, 2013 SAGE Presents New Mechanistic Insights On Novel Approach SAGE Presents New Mechanistic Insights On Novel Approach SAGE Presents New Mechanistic Insights On Novel Approach SAGE Presents New Mechanistic Insights On Novel Approach View HTML PDF Version Toggle SummaryOct 30, 2013 SAGE's Discovery of Novel Allosteric Therapeutic Approach for a Broad Range of CNS Disorders Published in Journal of Neuroscience SAGE's Discovery of Novel Allosteric Therapeutic Approach for a Broad Range of CNS Disorders Published in Journal of Neuroscience View HTML PDF Version Toggle SummaryOct 16, 2013 SAGE Therapeutics Secures $20M Series B Financing SAGE Therapeutics Secures $20M Series B Financing View HTML PDF Version Pagination First page First Previous page Previous … Page 30 Page 31 Page 32 Current page 33
Press Releases Year: - Any -20232022202120202019201820172016201520142013 Items per page 102550 Date Title View Toggle SummaryDec 19, 2013 SAGE Therapeutics Announces Collaboration with Washington University to Develop Novel GABA Receptor Small Molecules SAGE Therapeutics Announces Collaboration with Washington University to Develop Novel GABA Receptor Small Molecules View HTML PDF Version Toggle SummaryDec 9, 2013 SAGE Therapeutics Presents New Data Identifying Highly Selective, Oral Compounds and Novel Approach for the Treatment of Chronic Epilepsies SAGE Therapeutics Presents New Data Identifying Highly Selective, Oral Compounds and Novel Approach for the Treatment of Chronic Epilepsies View HTML PDF Version Toggle SummaryNov 18, 2013 SAGE's Novel Approach to Treatment of CNS Disorders to be Highlighted at Leading Industry and Scientific Conferences SAGE's Novel Approach to Treatment of CNS Disorders to be Highlighted at Leading Industry and Scientific Conferences View HTML PDF Version Toggle SummaryNov 12, 2013 SAGE Presents New Mechanistic Insights On Novel Approach SAGE Presents New Mechanistic Insights On Novel Approach SAGE Presents New Mechanistic Insights On Novel Approach SAGE Presents New Mechanistic Insights On Novel Approach View HTML PDF Version Toggle SummaryOct 30, 2013 SAGE's Discovery of Novel Allosteric Therapeutic Approach for a Broad Range of CNS Disorders Published in Journal of Neuroscience SAGE's Discovery of Novel Allosteric Therapeutic Approach for a Broad Range of CNS Disorders Published in Journal of Neuroscience View HTML PDF Version Toggle SummaryOct 16, 2013 SAGE Therapeutics Secures $20M Series B Financing SAGE Therapeutics Secures $20M Series B Financing View HTML PDF Version Pagination First page First Previous page Previous … Page 30 Page 31 Page 32 Current page 33
